Piper Jaffray upgrades Biosite Incorporated (BSTE) to Market Perform
More News related to BSTE
- Atticus Capital Boosts Stake in Inverness Medical (IMA) to 5.5%
- Piper Jaffray upgrades Biosite Incorporated (BSTE) to Market Perform
- Stifel Nicolaus Upgrades Inverness Medical Innovations (IMA) to Buy
- Largest $ Movers of Note - StreetInsider.com - 05/15/2007
- Inverness Medical Innovations (IMA) Raises Bid for Biosite (BSTE) to $92.50
More News related to IMA
- Capstone initiates Coverage on Inverness Medical Innovations (IMA) with a Buy
- Inverness Medical Innovations (IMA) Posts Q3 EPS of $0.74
- Inverness Medical Innovations Announces Third Quarter 2009 Results
- Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report
- Newly Acquired Free & Clear Announces Joint Collaboration with the American Cancer Society to Reduce Tobacco Use
More News related to Upgrades
- ex-Bear Stearn Hedge Fund Managers Cioffi and Tannin Acquitted
- Oil Drops on Weakened Tropical Storm Ida Outlook (USO, OIL, OIH, DIG)
- Priceline.com (PCLN) Earnings Boost Other Sector Stocks Up (OWW, EXPE, TZOO)
- Dow Surges 200 Points As G-20 Promises To Keep The Pump Primed
- Might Cisco (CSCO) and EMC (EMC) Look to Merge, or Simply Stay Friends With Benefits?
Piper Jaffray upgrades Biosite Incorporated (Nasdaq: BSTE) from Underperform to Market Perform and raises its price target to $92.50, citing increased level of confidence around the completion of the Inverness/Biosite acquisition.
Related Categories
UpgradesStocks Mentioned
-92.48
+0.40Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
